Profit Or Loss [Abstract]

Pharming Group N.V. - Filing #2154299

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
245,316,000 USD
205,622,000 USD
Other income
23,349,000 USD
14,523,000 USD
Profit (loss) from operating activities
5,387,000 USD
18,233,000 USD
Finance income
3,663,000 USD
4,485,000 USD
Finance costs
9,069,000 USD
5,463,000 USD
Profit (loss) before tax
12,012,000 USD
14,987,000 USD
Tax expense (income)
1,464,000 USD
1,313,000 USD
Profit (loss)
USD
10,548,000 USD
10,548,000 USD
USD
USD
USD
USD
13,674,000 USD
USD
13,674,000 USD
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.016
0.021
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.016
0.019

Talk to a Data Expert

Have a question? We'll get back to you promptly.